Stryker (SYK) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $3.52
- Estimate
- $3.55
- Surprise
- -0.8%
- Score at report (before → after)
- 6.0 → 6.1/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Stryker (SYK) missed the $3.55 estimate with adjusted EPS of $3.52 — a modest 0.8% shortfall. TrendMatrix's engine moved from Hold (6.0/10) to Sell at 6.1/10 after the report — the engine's score rose despite the miss.
Coverage in the report window
- Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $320 — benzinga, 2026-10-30
Where TrendMatrix's rating stands now
TrendMatrix currently rates SYK Sell at 6.1/10.
2 of the last 4 quarters beat the estimate; this quarter's -0.8% surprise compares with a -1.5% four-quarter average.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.5 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Product: MedSurg and Neurotechnology (62.0%)
- Concentration risk — Supplier: sole-source suppliers
- Thin upside margin: 4.7%
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $311.75
- Price target
- $326.35
- Stop
- $294.59
- Upside to target
- +4.7%
- Reward-to-risk
- 0.4:1
The stock trades at 32.3× trailing but 18.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 78 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-10-30 — shown for context, not personalized investment advice.
SYK at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $119.58B
- P/E (fwd)
- 18.7
- P/E (ttm)
- 32.3
- 52-week range
- $267.00–$389.33
- Off 52-week high
- 19.9%
- RSI (14)
- 78
- Volume vs avg
- 1.23×
- Score today
- 6.1/10